Treatment of children with haemophilia in Europe: A survey of 20 centres in 16 countries

Haemophilia

Volumn 6, Issue 6, 2000, Pages 619-624

  Ljung, R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Aronis Vournas, S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Kurnik Auberger, K ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Van Den Berg, M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Chambost, H ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Claeyssens, S ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Van Geet, C ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Glomstein, A ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Hann, I ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Hill, F ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Kobelt, R ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Kreuz, W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Mancuso, G ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Muntean, W ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Petrini, P ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Rosado, L ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Scheibel, E ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Siimes, M ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Smith, O ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}   Tusell, J ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u}  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b St Sophia's Children's Hospital   (Greece)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e TIMONE HOSPITAL   (France)

^f CHU PURPAN   (France)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h Institute for Hemophilia   (Norway)

ⁱ GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^j BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^k Hämophiliezentrum ^*  (Switzerland)

^l UNIVERSITY OF BERN   (Switzerland)

^m UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁿ UNIVERSITY OF PALERMO   (Italy)

^o Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

^p KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^q HOSPITAL DONA ESTEFÂNIA   (Portugal)

^r Rigshospitalet   (Denmark)

^s UNIVERSITY OF HELSINKI   (Finland)

^t ADELAIDE AND MEATH HOSPITAL   (Ireland)

^u HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

more..

Author keywords

Concentrate; Factor IX; Factor VIII; Haemophilia A.; Haemophilia B.; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9;

ADOLESCENT; ADULT; AGE; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG PREFERENCE; DRUG RESPONSE; EUROPE; HEALTH SURVEY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HOME CARE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL VEIN; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EUROPE; FACTOR IX; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; INFANT; MALE; OUTPATIENTS; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033670728     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2000.00427.x     Document Type: Article

References (16)

1. Frequency of inhibitor development in Haemophilia treated with low purity concentrates
2. Recombinant FVIII for the treatment of previously untreated patients with haemophilia A. Safety, efficacy and development of inhibitors
3. Previously untreated patients and recombinant FVIII concentrate studies
4. Incidence of inhibitors in haemophilia A patients-a review of recent studies of recombinant and plasma derived FVIII concentrates
5. Implantable venous access devices in children with hemophilia: A report of low infection rates
6. Port-A-Cath usage in children with haemophilia-experience of 53 cases
7. Prophylaxis with factor concentrates in preventing haemophilic arthropathy
8. Experiences with prophylaxis in Denmark
9. When should prophylactic treatment in patients with haemophilia A and B start?
10. Haemophilia prophylaxis in young patients-a long term follow-up
11. Primary prophylaxis in severe hemophilia should be started early but can be individualized
12. Pharmacokinetic dosing in prophylactic treatment of hemophilia A
13. Improved cost-effectiveness by pharmacokinetic dosing of Factor VIII in prophylactic treatment of haemophilia A
14. A radiologic classification of hemophilia arthropathy